Literature DB >> 7911178

Caesarean section and risk of vertical transmission of HIV-1 infection. The European Collaborative Study.

.   

Abstract

Indirect evidence suggests that a significant proportion of vertical transmission of HIV infection occurs late in pregnancy or during delivery. Caesarean section, therefore, may protect the fetus from infection. We looked at 1254 HIV-infected mothers and their children and the effects of different modes of delivery on transmission risk. We also included a detailed assessment of confounding factors associated with transmission risk. Women who had caesarean sections were more advanced in their disease progression which may cause the protective effect of caesarean section to be underestimated. When this and other potential confounding factors were taken into account, caesarean section was estimated to halve the rate of transmission. This finding is important in the design of studies to evaluate treatments aimed at reducing mother-to-child transmission.

Entities:  

Mesh:

Year:  1994        PMID: 7911178

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  25 in total

Review 1.  Prevention of perinatal HIV transmission: current status and future developments in anti-retroviral therapy.

Authors:  Athena P Kourtis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines).

Authors:  David R Burdge; Deborah M Money; John C Forbes; Sharon L Walmsley; Fiona M Smaill; Marc Boucher; Lindy M Samson; Marc Steben
Journal:  CMAJ       Date:  2003-06-24       Impact factor: 8.262

Review 3.  Infants born to HIV-1 infected women: lessons from the past decade.

Authors:  A Kaul; S Chandwani
Journal:  Indian J Pediatr       Date:  1995 Jan-Feb       Impact factor: 1.967

Review 4.  Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.

Authors:  H L Tillmann; M P Manns
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 5.  Options for prevention of HIV transmission from mother to child, with a focus on developing countries.

Authors:  Louise Kuhn; Ingrid Peterson
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 6.  A risk-benefit assessment of zidovudine in the prevention of perinatal HIV transmission.

Authors:  M L Newell; D M Gibb
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

Review 7.  Advances in prevention of mother-to-child HIV transmission.

Authors:  Chokechai Rongkavilit; Basim I Asmar
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 1.967

8.  Cost-effectiveness of Childbirth Strategies for Prevention of Mother-to-child Transmission of HIV Among Mothers Receiving Nevirapine in India.

Authors:  Kanchan Mukherjee
Journal:  Indian J Community Med       Date:  2010-01

9.  The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.

Authors:  Caitlin J McCabe; Sue J Goldie; David N Fisman
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

10.  Mother-to-child transmission of human immunodeficiency virus type 1: influence of parity and mode of delivery. Paediatric AIDS Group of Switzerland.

Authors:  C Kind
Journal:  Eur J Pediatr       Date:  1995-07       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.